-transparent.png){kind=logo}
The Authors consider the different opinions expressed about the HBsAg screening in blood donors and its usefulness in preventing post transfusional hepatitis B (PTHB). They report data on the incidence of such a disease, as observed in their transfusional experience during the last 5 years, with a comparison between results obtained after CEP and RIA screening systems. The Authors point out the results of their retrospective investigation: the transfusion blood with a low HBsAg titre showed to be more infectious than the blood with high titre. Consequently, it is necessary to use more sensitive methods for HBsAg screening and possibly to increase their sensitivity or to combine them with other methods fit to evidence further markers of virus B.
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
February 2004,
Scandinavian journal of gastroenterology,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
January 1988,
Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
June 1993,
Sangre,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
September 1989,
La Revue du praticien,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
January 1985,
Arquivos de gastroenterologia,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
September 1978,
Bollettino dell'Istituto sieroterapico milanese,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
January 1989,
Bollettino dell'Istituto sieroterapico milanese,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
November 1996,
Journal of hepatology,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
August 1968,
Prensa medica argentina,
G Bedarida, and
F D'Agostino, and
C Lavezzi, and
F Tamagni
January 1955,
Rivista di emoterapia ed immunoematologia,
